ヨーロッパのオンライン薬局市場調査レポート : 2027年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2023年3月

Europe Epharmacy Market Research Report Forecast to 2027
ヨーロッパのオンライン薬局市場調査レポート : 2027年までの予測

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

Europe Epharmacy Market Research Report Forecast to 2027

Market Overview
The growth of the Europe ePharmacy market is attributed to the rising occurrence of chronic and infectious diseases and an increase in the number of patients with multimorbidity. However, the availability of illegitimate online pharmacies in the market may hamper the market growth. Furthermore, the increasing adoption rate of the Internet and healthcare apps provides lucrative opportunities for the players operating in the market.
An ePharmacy—also called online pharmacy—operates via the Internet and sells items such as drugs, medicines, food supplements, cosmetics products, and medical devices. It can offer services such as ePrescribing, locating a pharmacy, services for new medications, checking stock, online consultation, ordering over-the-counter drugs online with consultation, monitoring, reminders, and management of clinical information.
The key factors driving the Europe ePharmacy market growth are the rising occurrence of chronic and infectious diseases, the increase of patients with multimorbidity, and lucrative investment for ePharmacy startups. However, the availability of illegitimate online pharmacies and data security may hamper the market’s growth. The increasing adoption rate of internet and healthcare apps creates an opportunity to propel the ePharmacy market.

Market Segmentation
Based on type, the Europe ePharmacy market is segmented into prescription and over-the-counter (OTC). Based on product type, the Europe ePharmacy market is segmented into chronic drugs, acute drugs, nutrition, dermo-cosmetics, personal care, and others. The other product segment includes medical devices, medical supplies, food, parnuts, and among others.
Based on operating platforms, the Europe ePharmacy market has been segmented into website and apps.

Major Players
Zur Rose Group (Switzerland), Shop Apotheke Europe (Netherlands), Apoteket AB (Sweden), lloydspharmacy (UK), Medpex (Germany), Medikamente-per-klick.de (Germany), apotal.de (Germany), and Viata online pharmacy (Belgium).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 RISING OCCURRENCE OF CHRONIC AND INFECTIOUS DISEASES
4.2.2 INCREASING PATIENTS WITH MULTIMORBIDITIES
4.2.3 LUCRATIVE INVESTMENT FOR EPHARMACY STARTUPS
4.3 RESTRAINTS
4.3.1 AVAILABILITY OF ILLEGITIMATE ONLINE PHARMACIES
4.3.2 DATA SECURITY
4.4 OPPORTUNITIES
4.4.1 INCREASING ADOPTION RATE OF INTERNET AND HEALTHCARE APPS
4.5 CHALLENGES
4.5.1 REGULATORY RESTRICTIONS RELATED TO EPHARMACY
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
5.1.2 SERVICE CUSTOMIZATION
5.1.3 CUSTOMER PURCHASE SUPPORT
5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON EPHARMACY MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON SUPPLY OF MEDICINES
5.3.3 IMPACT ON MAJOR PLAYERS
5.3.4 IMPACT ON AVAILABILITY OF PRODUCTS/SERVICES
5.4 REGULATORY LANDSCAPE FOR E-PHARMACIES IN EUROPE
5.4.1 REGULATORY LANDSCAPE BY COUNTRY
6 EUROPE EPHARMACY MARKET, BY TYPE
6.1 OVERVIEW
6.2 PRESCRIPTION
6.3 OVER THE COUNTER (OTC)
7 EUROPE EPHARMACY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 CHRONIC DRUGS
7.3 ACUTE DRUGS
7.4 NUTRITION
7.5 DERMO COSMETICS
7.6 PERSONAL CARE
7.7 OTHERS
8 EUROPE EPHARMACY MARKET, BY OPERATING PLATFORM
8.1 OVERVIEW
8.2 WEBSITE
8.3 APPS
9 EUROPE EPHARMACY MARKET, BY COUNTRY
9.1 OVERVIEW
9.2 GERMANY
9.3 FRANCE
9.4 UK
9.5 ITALY
9.6 SPAIN
9.7 PORTUGAL
9.8 NETHERLANDS
9.9 TURKEY
9.10 CZECH REPUBLIC
9.11 ROMANIA
9.12 LITHUANIA
9.13 NORWAY
9.14 REST OF EUROPE
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE EUROPE EPHARMACY MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE EPHARMACY MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL
10.6.2 MERGER/ACQUISITION
10.6.3 PARTNERSHIP/ AGREEMENT
10.7 FINANCIAL MATRIX
10.7.1 SALES (USD MILLION), 2020
10.8 LIST OF MAJOR START-UPS
11 COMPANY PROFILES
11.1 DR. FOX PHARMACY
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCT/SERVICE OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 VIATA ONLINE PHARMACY
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCT/SERVICE OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 BESTWAY GROUP LIMITED (WELL PHARMACY)
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCT/SERVICE OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 LLOYDS PHARMACY
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCT/SERVICE OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 APOTEK AB
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCT/SERVICE OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 SHOP APOTHEKE EUROPE
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCT/SERVICE OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 DR.MAX PHARMACY
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCT/SERVICE OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 ZUR ROSE GROUP (DOCMORRIS N.V.)
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCT/SERVICE OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 MEDPEX
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCT/SERVICE OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 MEDIKAMENTE-PER-KLICK.DE
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCT/SERVICE OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
11.11 APOTAL.DE
11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCT/SERVICE OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 KEY STRATEGIES
11.12 PEARS HEALTH CYBER, SRO (LEKARNA.CZ)
11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL OVERVIEW
11.12.3 PRODUCT/SERVICE OFFERED
11.12.4 KEY DEVELOPMENTS
11.12.5 KEY STRATEGIES
11.13 FARMASIET
11.13.1 COMPANY OVERVIEW
11.13.2 FINANCIAL OVERVIEW
11.13.3 PRODUCT/SERVICE OFFERED
11.13.4 KEY DEVELOPMENTS
11.13.5 KEY STRATEGIES
12 EUROPE EPHARMACY MARKET, KEY QUESTIONS BY COUNTRY
12.1 ELECTRONIC PRESCRIPTIONS
12.2 OTC SALES
12.3 PARA-PHARMACY
12.4 ONLINE PAYMENTS
12.5 DELIVERY
12.6 CENTRAL PRICING STRATEGY
12.7 SKUS BY MARKET OF COMPETITORS AND WHAT IS OVERALL 80/20 DISTRIBUTION OF SKU
12.8 CLICK AND COLLECT
12.9 LOYALTY CARD ALLOWED FOR OTC AND PARA
12.10 ADVERTISING AND DISCOUNTING
12.11 PRICE ANALYSIS FOR ONLINE VS BRICK AND MORTAR PHARMACIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 REGULATORY LANDSCAPE BY COUNTRY
TABLE 4 EUROPE: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 5 EUROPE: EPHARMACY MARKET, FOR PRESCRIPTION, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 6 EUROPE: EPHARMACY MARKET, FOR OTC, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 7 EUROPE: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 8 EUROPE: EPHARMACY MARKET, FOR CHRONIC DRUGS, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 9 EUROPE: EPHARMACY MARKET, FOR ACUTE DRUGS, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 10 EUROPE: EPHARMACY MARKET, FOR NUTRITION, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 11 EUROPE: EPHARMACY MARKET, FOR DERMO COSMETICS, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 12 EUROPE: EPHARMACY MARKET, FOR PERSONAL CARE, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 13 EUROPE: EPHARMACY MARKET, FOR OTHERS, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 14 EUROPE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 15 EUROPE: EPHARMACY MARKET, FOR WEBSITE, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 16 EUROPE: EPHARMACY MARKET, FOR APPS, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 17 EUROPE: EPHARMACY MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 18 GERMANY: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 19 GERMANY: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 20 GERMANY: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 21 FRANCE: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 22 FRANCE: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 23 FRANCE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 24 UK: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 25 UK: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 26 UK: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 27 ITALY: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 28 ITALY: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 29 ITALY: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 30 SPAIN: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 31 SPAIN: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 32 SPAIN: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 33 PORTUGAL: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 34 PORTUGAL: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 35 PORTUGAL: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 36 NETHERLANDS: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 37 NETHERLANDS: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 38 NETHERLANDS: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 39 TURKEY: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 40 TURKEY: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 41 TURKEY: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 42 CZECH REPUBLIC: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 43 CZECH REPUBLIC: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 44 CZECH REPUBLIC: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 45 ROMANIA: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 46 ROMANIA: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 47 ROMANIA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 48 LITHUANIA: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 49 LITHUANIA: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 50 LITHUANIA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 51 NORWAY: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 52 NORWAY: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 53 NORWAY: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 54 REST OF EUROPE: EPHARMACY MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 55 REST OF EUROPE: EPHARMACY MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 56 REST OF EUROPE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2018–2027 (USD MILLION)
TABLE 57 MAJOR PLAYERS IN THE EUROPE EPHARMACY MARKET
TABLE 58 MOST ACTIVE PLAYER IN THE EUROPE EPHARMACY MARKET
TABLE 59 PRODUCT LAUNCH/ PRODUCT APPROVAL
TABLE 60 MERGER/ACQUISITION
TABLE 61 PARTNERSHIP/ AGREEMENT
TABLE 62 LIST OF MAJOR START-UPS
TABLE 63 DR. FOX PHARMACY: PRODUCT/SERVICE OFFERED
TABLE 64 VIATA ONLINE PHARMACY: PRODUCT/SERVICE OFFERED
TABLE 65 BESTWAY GROUP LIMITED (WELL PHARMACY): PRODUCT/SERVICE OFFERED
TABLE 66 BESTWAY GROUP LIMITED (WELL PHARMACY).: KEY DEVELOPMENTS
TABLE 67 LLOYDS PHARMACY: PRODUCT/SERVICE OFFERED
TABLE 68 LLOYDS PHARMACY: KEY DEVELOPMENTS
TABLE 69 APOTEKET AB: PRODUCT/SERVICE OFFERED
TABLE 70 SHOP APOTHEKE EUROPE: PRODUCT/SERVICE OFFERED
TABLE 71 SHOP APOTHEKE EUROPE: KEY DEVELOPMENTS
TABLE 72 DR. MAX PHARMACY: PRODUCT/SERVICE OFFERED
TABLE 73 DR. MAX PHARMACY: KEY DEVELOPMENTS
TABLE 74 ZUR ROSE GROUP: PRODUCT/SERVICE OFFERED
TABLE 75 ZUR ROSE GROUP: KEY DEVELOPMENTS
TABLE 76 MEDPEX: PRODUCT/SERVICE OFFERED
TABLE 77 MEDIKAMENTE-PER-KLICK.DE: PRODUCT/SERVICE OFFERED
TABLE 78 APOTAL.DE: PRODUCT/SERVICE OFFERED
TABLE 79 PEARS HEALTH CYBER, SRO (LEKARNA.CZ): PRODUCT/SERVICE OFFERED
TABLE 80 FARMASIET: PRODUCT/SERVICE OFFERED
TABLE 81 FARMASIET: KEY DEVELOPMENTS
TABLE 82 ELECTRONIC PRESCRIPTIONS
TABLE 83 OTC SALES
TABLE 84 PARA-PHARMACY
TABLE 85 ONLINE PAYMENTS
TABLE 86 DELIVERY
TABLE 87 CENTRAL PRICING STRATEGY
TABLE 88 SKUS BY MARKET OF COMPETITORS AND WHAT IS OVERALL 80/20 DISTRIBUTION OF SKU
TABLE 89 CLICK AND COLLECT
TABLE 90 LOYALTY CARD ALLOWED FOR OTC AND PARA
TABLE 91 ADVERTISING AND DISCOUNTING
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 EUROPE EPHARMACY MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: EUROPE EPHARMACY MARKET
FIGURE 5 DRIVERS: IMPACT ANALYSIS
FIGURE 6 RESTRAINTS: IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: EPHARMACY MARKET
FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: EPHARMACY MARKET
FIGURE 9 EUROPE EPHARMACY MARKET, BY TYPE, 2020 & 2027 (USD MILLION)
FIGURE 10 EUROPE: EPHARMACY MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION)
FIGURE 11 EUROPE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2020 & 2027 (USD MILLION)
FIGURE 12 EUROPE: EPHARMACY MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 13 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 14 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE EUROPE EPHARMACY MARKET
FIGURE 15 EUROPE EPHARMACY MARKET: COMPETITIVE LANDSCAPE
FIGURE 16 SALES 2020
FIGURE 17 DR. FOX PHARMACY: SWOT ANALYSIS
FIGURE 18 VIATA ONLINE PHARMACY.: SWOT ANALYSIS
FIGURE 19 BESTWAY GROUP LIMITED (WELL PHARMACY).: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 LLOYDS PHARMACY.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 APOTEKET AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 APOTEKET AB: SWOT ANALYSIS
FIGURE 23 SHOP APOTHEKE EUROPE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 SHOP APOTHEKE EUROPE: SWOT ANALYSIS
FIGURE 25 ZUR ROSE GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 ZUR ROSE GROUP: SWOT ANALYSIS
FIGURE 27 FARMASIET: FINANCIAL OVERVIEW SNAPSHOT